2015-2017年澳大利亚全科诊所成人流感免疫覆盖率全国研究
该研究基于MedicineInsight数据库550家澳大利亚全科诊所的开放队列,评估2015-2017年流感季就诊成人的疫苗接种率与覆盖率。结果显示活跃患者覆盖率从29.3%降至25.2%再升至27.6%,65岁以上、有合并症及内区域地区患者覆盖率至少高30%,原住民覆盖率较非原住民高10-30%。结论认为该数据可用于低成本监测,但高风险群体覆盖率仍需提升。
要点
- 2015-2017年活跃患者流感疫苗覆盖率分别为29.3%、25.2%、27.6%。
- 65岁以上、有合并症及内区域地区患者覆盖率至少高30%。
- 65岁以下原住民覆盖率较非原住民高10-30%(交互P<0.001)。
核心结论
- MedicineInsight数据是监测流感免疫覆盖率的实用低成本方法。
- 原住民及有合并症患者的疫苗接种覆盖率仍有提升空间,需制定针对高风险群体的策略。
研究设计与样本
- 开放队列研究,纳入MedicineInsight数据库中550家澳大利亚全科诊所。
- 研究对象为2015-2017年流感季至少就诊一次的18岁以上患者,分析活跃患者和每年患者两个样本。
主要发现
- 2015-2017年流感疫苗接种率从57.4降至51.7再升至67.0每千次就诊。
- 活跃患者覆盖率分别为29.3%、25.2%、27.6%。
- 内区域地区、65岁以上或有合并症患者覆盖率至少高30%。
- 每年患者三年平均覆盖率高于活跃患者(41% vs 27%)。
- 65岁以下原住民(无论有无合并症)覆盖率较非原住民高10-30%(交互P<0.001)。
临床怎么用
- 可利用全科诊所常规数据低成本监测流感免疫覆盖率。
- 应针对原住民和有合并症患者制定靶向策略以提高接种率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess influenza immunisation rates and coverage in adult patients from Australian general practice and identify whether practice or patients' characteristics are associated with vaccination uptake. DESIGN: Open cohort study. SETTING: 550 Australian general practices included in the MedicineInsight database. PARTICIPANTS: Patients aged 18+ years who had at least one consultation during influenza season between 2015 and 2017. Two samples were considered: (1) 'active' patients (at least three consultations in any two consecutive years) and (2) 'every year' patients (at least one consultation per year). MAIN OUTCOME MEASURES: Influenza vaccination rates per 1,000 consultations and coverage (% vaccinated among those who consulted) from 2015 to 2017. RESULTS: Between 2015 and 2017 the influenza vaccine rate changed from 57.4 to 51.7 and 67.0 per 1,000 consultations, while correspondent values for coverage were 29.3%, 25.2% and 27.6% (in 'active' patients). Vaccine coverage was at least 30% higher in inner regional areas, among patients aged 65+ years or those with comorbidities. Similar associations were found among 'every year' patients, but average coverage across the three years was higher (41% vs 27%). Aboriginal and Torres Strait Islander people, either with or without comorbidity, showed a vaccine coverage 10-30% higher than non-Indigenous people for those aged less than 65 years (p-value for interaction < 0.001). CONCLUSION: MedicineInsight data is a useful and low-cost method to monitor influenza immunisation coverage. Independent of the sample used, vaccination coverage among Indigenous people or patients with comorbidities could be improved. Targeted strategies for high-risk groups need to be developed.
引用
- De Oliveira Bernardo C, González-Chica DA, Chilver M, et al. Influenza immunisation coverage from 2015 to 2017: A national study of adult patients from Australian general practice. Vaccine. 2019. PMID: 31253446. doi:10.1016/j.vaccine.2019.06.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。